StockData
Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc. (RYTM) stock

RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)

Close on Nov 17, 2026Market cap $8.03BP/E –Yield –

Rhythm Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rhythm Pharmaceuticals's market cap was $7.72B on Nov 11, 2026, against $7.27B a year earlier. Over the last 5 years it ranged from $173.35M to $7.72B, with a median of $2.72B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.72B+8.1%
2025Dec 31, 2025$7.14B+107.5%
2024Dec 31, 2024$3.44B+26.6%
2023Dec 29, 2023$2.72B+67.3%
2022Dec 30, 2022$1.62B+223.6%
2021Dec 31, 2021$501.68M-61.8%
2020Dec 31, 2020$1.31B+65.5%
2019Dec 31, 2019$793.92M-14.1%
2018Dec 31, 2018$924.20M+1696.5%
2017Dec 29, 2017$51.44M–

More Rhythm Pharmaceuticals figures

See a number that looks wrong?